Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Catheter Precision Inc (AMEX: VTAK) closed the day trading at $0.21 down -30.50% from the previous closing price of $0.30. In other words, the price has decreased by -$30.50 from its previous closing price. On the day, 1.49 million shares were traded.
Ratios:
For a better understanding of VTAK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.19 and its Current Ratio is at 0.21. In the meantime, Its Debt-to-Equity ratio is 1.53 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Jaffray on August 13, 2019, Downgraded its rating to Neutral and sets its target price to $1.50 from $9 previously.
On November 02, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $23.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 ’25 when COLOMBATTO MARTIN J sold 3 shares for $0.40 per share. The transaction valued at 1 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.82 while its Price-to-Book (P/B) ratio in mrq is 0.25.
Stock Price History:
Over the past 52 weeks, VTAK has reached a high of $8.40, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -34.40%, while the 200-Day Moving Average is calculated to be -59.51%.
Shares Statistics:
A total of 11.02M shares are outstanding, with a floating share count of 10.32M. Insiders hold about 6.33% of the company’s shares, while institutions hold 5.34% stake in the company.
